Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis

Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is an age-associated progressive lung disease with accumulation of scar tissue impairing gas exchange. Previous high-throughput studies elucidated the role of cellular heterogeneity and molecular pathways in advanced disease. However, critical...

Full description

Bibliographic Details
Main Authors: Minxue Jia, Lorena Rosas, Maria G. Kapetanaki, Tracy Tabib, John Sebrat, Tamara Cruz, Anna Bondonese, Ana L. Mora, Robert Lafyatis, Mauricio Rojas, Panayiotis V. Benos
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-023-02419-0
_version_ 1797840887352393728
author Minxue Jia
Lorena Rosas
Maria G. Kapetanaki
Tracy Tabib
John Sebrat
Tamara Cruz
Anna Bondonese
Ana L. Mora
Robert Lafyatis
Mauricio Rojas
Panayiotis V. Benos
author_facet Minxue Jia
Lorena Rosas
Maria G. Kapetanaki
Tracy Tabib
John Sebrat
Tamara Cruz
Anna Bondonese
Ana L. Mora
Robert Lafyatis
Mauricio Rojas
Panayiotis V. Benos
author_sort Minxue Jia
collection DOAJ
description Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is an age-associated progressive lung disease with accumulation of scar tissue impairing gas exchange. Previous high-throughput studies elucidated the role of cellular heterogeneity and molecular pathways in advanced disease. However, critical pathogenic pathways occurring in the transition of fibroblasts from normal to profibrotic have been largely overlooked. Methods We used single cell transcriptomics (scRNA-seq) from lungs of healthy controls and IPF patients (lower and upper lobes). We identified fibroblast subclusters, genes and pathways associated with early disease. Immunofluorescence assays validated the role of MOXD1 early in fibrosis. Results We identified four distinct fibroblast subgroups, including one marking the normal-to-profibrotic state transition. Our results show for the first time that global downregulation of ribosomal proteins and significant upregulation of the majority of copper-binding proteins, including MOXD1, mark the IPF transition. We find no significant differences in gene expression in IPF upper and lower lobe samples, which were selected to have low and high degree of fibrosis, respectively. Conclusions Early events during IPF onset in fibroblasts include dysregulation of ribosomal and copper-binding proteins. Fibroblasts in early stage IPF may have already acquired a profibrotic phenotype while hallmarks of advanced disease, including fibroblast foci and honeycomb formation, are still not evident. The new transitional fibroblasts we discover could prove very important for studying the role of fibroblast plasticity in disease progression and help develop early diagnosis tools and therapeutic interventions targeting earlier disease states.
first_indexed 2024-04-09T16:22:04Z
format Article
id doaj.art-dde4cdd40c214eafbea635dd5cd10002
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-04-09T16:22:04Z
publishDate 2023-04-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-dde4cdd40c214eafbea635dd5cd100022023-04-23T11:26:09ZengBMCRespiratory Research1465-993X2023-04-0124111310.1186/s12931-023-02419-0Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosisMinxue Jia0Lorena Rosas1Maria G. Kapetanaki2Tracy Tabib3John Sebrat4Tamara Cruz5Anna Bondonese6Ana L. Mora7Robert Lafyatis8Mauricio Rojas9Panayiotis V. Benos10Department of Computational and Systems Biology, University of PittsburghDepartment of Internal Medicine, Division Pulmonary, Critical Care and Sleep Medicine, The Ohio State UniversityDepartment of Computational and Systems Biology, University of PittsburghDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of MedicineDepartment of Internal Medicine, Division Pulmonary, Critical Care and Sleep Medicine, The Ohio State UniversityDepartment of Internal Medicine, Division Pulmonary, Critical Care and Sleep Medicine, The Ohio State UniversityDepartment of Internal Medicine, Division Pulmonary, Critical Care and Sleep Medicine, The Ohio State UniversityDepartment of Internal Medicine, Division Pulmonary, Critical Care and Sleep Medicine, The Ohio State UniversityDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of MedicineDepartment of Internal Medicine, Division Pulmonary, Critical Care and Sleep Medicine, The Ohio State UniversityDepartment of Computational and Systems Biology, University of PittsburghAbstract Background Idiopathic Pulmonary Fibrosis (IPF) is an age-associated progressive lung disease with accumulation of scar tissue impairing gas exchange. Previous high-throughput studies elucidated the role of cellular heterogeneity and molecular pathways in advanced disease. However, critical pathogenic pathways occurring in the transition of fibroblasts from normal to profibrotic have been largely overlooked. Methods We used single cell transcriptomics (scRNA-seq) from lungs of healthy controls and IPF patients (lower and upper lobes). We identified fibroblast subclusters, genes and pathways associated with early disease. Immunofluorescence assays validated the role of MOXD1 early in fibrosis. Results We identified four distinct fibroblast subgroups, including one marking the normal-to-profibrotic state transition. Our results show for the first time that global downregulation of ribosomal proteins and significant upregulation of the majority of copper-binding proteins, including MOXD1, mark the IPF transition. We find no significant differences in gene expression in IPF upper and lower lobe samples, which were selected to have low and high degree of fibrosis, respectively. Conclusions Early events during IPF onset in fibroblasts include dysregulation of ribosomal and copper-binding proteins. Fibroblasts in early stage IPF may have already acquired a profibrotic phenotype while hallmarks of advanced disease, including fibroblast foci and honeycomb formation, are still not evident. The new transitional fibroblasts we discover could prove very important for studying the role of fibroblast plasticity in disease progression and help develop early diagnosis tools and therapeutic interventions targeting earlier disease states.https://doi.org/10.1186/s12931-023-02419-0Idiopathic Pulmonary FibrosisFibroblastsCopperRibosomal proteinsMOXD1scRNA-seq
spellingShingle Minxue Jia
Lorena Rosas
Maria G. Kapetanaki
Tracy Tabib
John Sebrat
Tamara Cruz
Anna Bondonese
Ana L. Mora
Robert Lafyatis
Mauricio Rojas
Panayiotis V. Benos
Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis
Respiratory Research
Idiopathic Pulmonary Fibrosis
Fibroblasts
Copper
Ribosomal proteins
MOXD1
scRNA-seq
title Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis
title_full Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis
title_fullStr Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis
title_full_unstemmed Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis
title_short Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis
title_sort early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis
topic Idiopathic Pulmonary Fibrosis
Fibroblasts
Copper
Ribosomal proteins
MOXD1
scRNA-seq
url https://doi.org/10.1186/s12931-023-02419-0
work_keys_str_mv AT minxuejia earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT lorenarosas earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT mariagkapetanaki earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT tracytabib earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT johnsebrat earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT tamaracruz earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT annabondonese earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT analmora earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT robertlafyatis earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT mauriciorojas earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis
AT panayiotisvbenos earlyeventsmarkinglungfibroblasttransitiontoprofibroticstateinidiopathicpulmonaryfibrosis